Table. 1 Participant demographics and clinical characteristics
From: Remote real time digital monitoring fills a critical gap in the management of Parkinson’s disease
Characteristic | n (%) |
|---|---|
Age | |
Mean ± SD (years)a | 67.0 ± 8.9 |
Range | 50–83 |
Sex | N = 30 |
Male | 23 (76.7) |
Female | 7 (23.3) |
Race/Ethnicity | N = 30 |
White | 24 (80.0) |
Asian | 5 (16.7) |
Hispanic or Latino | 1 (3.3) |
Diagnosis at Time of Referral | N = 30 |
Established PD | 24 (80.0) |
Essential Tremor | 2 (6.7) |
Tremorb | 2 (6.7) |
Mild Cognitive Impairment | 1 (3.3) |
Dream Enactment | 1 (3.3) |
Years Since PD Diagnosisa | N = 25 |
<5 years | 7 (28.0) |
5–10 years | 4 (16.0) |
10–15 years | 10 (40.0) |
>15 years | 4 (16.0) |
ON Therapy MDS-UPDRS IIIc | N = 28 |
Mean ± SD | 15.3 ± 7.1 |
Range | 2–26 |
Reason For Referral | N = 30 |
Medication response monitoring | 18 (60.0) |
Motor fluctuation | 12 |
Adherence | 4 |
Medication initiation | 2 |
Motor monitoring | 7 (23.3) |
Pre-diagnostic assessment | 4 (13.3) |
DBS programming | 1 (3.3) |
